Technical Analysis for HQL - H&Q Life Sciences Investors
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Stochastic Reached Overbought | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Narrow Range Bar | Range Contraction | 0.64% | |
180 Bullish Setup | Bullish Swing Setup | 0.64% | |
Pocket Pivot | Bullish Swing Setup | 0.64% | |
Outside Day | Range Expansion | 0.64% | |
Overbought Stochastic | Strength | 0.64% | |
Earnings Movers | Other | 1.35% |
Alert | Time |
---|---|
Bullish 180 Entry | 3 days ago |
Rose Above Previous Day's High | 3 days ago |
2x Volume Pace | 3 days ago |
1.5x Volume Pace | 3 days ago |
Fell Below Previous Day's Low | 4 days ago |
Get a Trading Assistant
- Earnings date: 08/06/2024
H&Q Life Sciences Investors Description
H&Q Life Sciences Investors is a close ended equity mutual fund launched and managed by Hambrecht & Quist Capital Management, LLC. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating in the health technology and life sciences industries. It also invests in stocks of early and later stage financings of privately held companies, private placements by public companies. The fund invests in growth stocks of companies operating across all market capitalizations. It employs fundamental analysis with a focus on factors such as potential for above-average, long-term growth in revenues and earnings securities strong market position for their services or products, experienced business management, and, recognized technological expertise. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. H&Q Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Classification
Sector: Financial Services
Industry: Asset Management
Keywords: Stock Fund Business Management Health Technology Nasdaq Biotech Experienced Business Management
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 14.3 |
52 Week Low | 10.3872 |
Average Volume | 74,736 |
200-Day Moving Average | 12.54 |
50-Day Moving Average | 13.44 |
20-Day Moving Average | 13.86 |
10-Day Moving Average | 13.99 |
Average True Range | 0.16 |
RSI (14) | 69.70 |
ADX | 32.82 |
+DI | 36.71 |
-DI | 13.72 |
Chandelier Exit (Long, 3 ATRs) | 13.82 |
Chandelier Exit (Short, 3 ATRs) | 13.50 |
Upper Bollinger Bands | 14.32 |
Lower Bollinger Band | 13.41 |
Percent B (%b) | 0.94 |
BandWidth | 6.54 |
MACD Line | 0.21 |
MACD Signal Line | 0.18 |
MACD Histogram | 0.0266 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 14.38 | ||||
Resistance 3 (R3) | 14.37 | 14.31 | 14.36 | ||
Resistance 2 (R2) | 14.31 | 14.28 | 14.32 | 14.35 | |
Resistance 1 (R1) | 14.29 | 14.26 | 14.30 | 14.30 | 14.35 |
Pivot Point | 14.23 | 14.23 | 14.24 | 14.24 | 14.23 |
Support 1 (S1) | 14.21 | 14.20 | 14.22 | 14.22 | 14.17 |
Support 2 (S2) | 14.15 | 14.18 | 14.16 | 14.17 | |
Support 3 (S3) | 14.13 | 14.15 | 14.16 | ||
Support 4 (S4) | 14.14 |